[
    {
        "other_ids": [
            {
                "name": "Study Protocol Other Identifier",
                "value": "2016-003022-17"
            }
        ],
        "amendment_date": null,
        "keywords": [
            "PIK3CA mutant",
            "Breast Cancer"
        ],
        "dcp_id": null,
        "interventional_model": "SEQUENTIAL_ASSIGNMENT",
        "lead_org": "Genentech Inc.",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 0,
                    "description": "Evaluable or measurable disease per RECIST, Version 1.1 (measurable disease only for Arm D)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 1,
                    "description": "Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 2,
                    "description": "Life expectancy of greater than or equal to (\u2265) 12 weeks"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 3,
                    "description": "Adequate hematologic and organ function, including blood counts, liver and kidney function Stage I Arm A (Inavolisib):"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 4,
                    "description": "Locally advanced, recurrent, or metastatic, PIK3CA mutant, incurable solid tumor malignancy, including breast cancer Stages I and II, Arms B and C:"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 5,
                    "description": "Postmenopausal female participants with locally advanced or metastatic PIK3CA-mutant HR+/HER2- breast cancer Stage II, Arms D, E, or F:"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 6,
                    "description": "Female participants with locally advanced or metastatic PIK3CA-mutant HR+/HER2- breast cancer Stage II Arm D:"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 7,
                    "description": "Prior treatment with CDK4/6 inhibitor Stage II Arm G:"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 8,
                    "description": "Female participants with locally advanced or metastatic PIK3CA-mutant HER2+ breast cancer"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 9,
                    "description": "Left ventricular ejection fraction 50% or greater Stages I and II:"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 10,
                    "description": "All participants must provide tumor tissue from the primary or metastatic tumor site obtained from a prior or new biopsy or surgical procedure for detection of PIK3CA mutation by central laboratory test."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 11,
                    "description": "Metaplastic breast cancer"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 12,
                    "description": "History of leptomeningeal disease"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 13,
                    "description": "Type 1 or 2 diabetes requiring anti-hyperglycemic medication"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 14,
                    "description": "Inability or unwillingness to swallow pills"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 15,
                    "description": "Malabsorption syndrome or other condition that would interfere with enteral absorption"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 16,
                    "description": "Known and untreated, or active central nervous system metastases"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 17,
                    "description": "Uncontrolled pleural effusion or ascites"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 18,
                    "description": "Any active infection that could impact patient safety or serious infection requiring intravenous antibiotics"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 19,
                    "description": "History of other malignancy within 5 years, except for treated carcinoma in situ of the cervix, non-melanoma skin carcinoma, or Stage I uterine cancer"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 20,
                    "description": "History of or active ventricular dysrhythmias or congestive heart failure requiring medication or symptomatic coronary heart disease"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 21,
                    "description": "Congenital long QT syndrome, prolonged QT interval, or family history of sudden unexplained death or long QT syndrome Stage II Arms B, C, D, and E only:"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 22,
                    "description": "Prior treatment with >1 chemotherapy regimen for metastatic disease"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 23,
                    "description": "Prior treatment with PI3K inhibitor"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 24,
                    "description": "History of significant toxicity related to mTOR inhibitor requiring treatment discontinuation Stage II Arms B and E only:"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 25,
                    "description": "Prior CDK4/6 inhibitor treatment Stage II Arm G only:"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 26,
                    "description": "Current uncontrolled hypertension or unstable angina"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 27,
                    "description": "History of congestive heart failure, serious cardiac arrhythmia, or recent myocardial infarction"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 28,
                    "description": "Prior ejection fraction decrease on trastuzumab"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 29,
                    "description": "Prior cumulative doxorubicin greater than 360 mg/m2"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 30,
                    "description": "Symptomatic active lung disease"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 31,
                    "description": "History of significant toxicity related to trastuzumab and/or pertuzumab requiring discontinuation of treatment"
                }
            ],
            "structured": {
                "max_age": "999 Years",
                "max_age_number": 999.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 999.0,
                "gender": "BOTH",
                "accepts_healthy_volunteers": false,
                "min_age": "18 Years",
                "min_age_number": 18.0,
                "min_age_in_years": 18.0
            }
        },
        "completion_date_type_code": "ANTICIPATED",
        "detail_description": null,
        "official_title": "A Phase I, Open-Label, Dose-Escalation Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0077 as a Single Agent in Patients With Locally Advanced or Metastatic PIK3CA-Mutant Solid Tumors and in Combination With Endocrine and Targeted Therapies in Patients With Locally Advanced or Metastatic PIK3CA-Mutant Breast Cancer",
        "_phase_sort_order": 4,
        "collaborators": [],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "Predose (0-2 hours before dosing) on Cycle 1 Day 1 up to EOS (up to approximately 6 years); Cycle length=28 days (Cycle 1 of Stage 1 Arm A=35 days)",
                "name": "Accumulation Ratio (AR) of Inavolisib at Steady-State",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Predose (0-2 hours before dosing) on Cycle 1 Day 1 up to EOS (up to approximately 6 years); Cycle length=28 days (Cycle 1 of Stage 1 Arm A=35 days)",
                "name": "Apparent Clearance (CL/F) of Inavolisib",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Predose (0-2 hours before dosing) on Cycle 1 Day 1 up to end of study (EOS; up to approximately 6 years); Cycle length=28 days (Cycle 1 of Stage 1 Arm A=35 days)",
                "name": "Area Under the Concentration Time-Curve (AUC) from Time Zero to Infinity (AUCinf) of Inavolisib",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Predose (0-2 hours before dosing) on Cycle 1 Day 1 up to EOS (up to approximately 6 years); Cycle length=28 days (Cycle 1 of Stage 1 Arm A=35 days)",
                "name": "AUC from Time Zero to Dosing Interval (AUC0-tau) of Inavolisib",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Predose (0-2 hours before inavolisib dosing) on Cycle 1 Day 1 up to EOS (up to approximately 6 years); Cycle length=28 days",
                "name": "AUC of Fulvestrant",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Predose (0-2 hours before inavolisib dosing) on Cycle 1 Day 1 up to EOS (up to approximately 6 years); Cycle length=28 days",
                "name": "AUC of Letrozole",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Predose (0-2 hours before inavolisib) dosing) on Cycle 1 Day 1 up to Cycle 6; Cycle length=28 days",
                "name": "AUC of Palbociclib",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Predose (0-2 hours before inavolisib dosing) on Cycle 1 Day 1 up to EOS (up to approximately 6 years); Cycle length=21 days",
                "name": "AUC of Pertuzumab",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Predose (0-2 hours before inavolisib dosing) on Cycle 1 Day 1 up to EOS (up to approximately 6 years); Cycle length=21 days",
                "name": "AUC of Trastuzumab",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Baseline, Week 2",
                "name": "Change in Maximum Standard Uptake Value (SUV) of Tumor Regions of Interest (as assessed by [18] F-fluorodeoxyglucose-positron emission tomography) From Baseline to Approximately 2 Weeks of Inavolisib Treatment",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Predose (0-2 hours before inavolisib dosing) on Cycle 1 Day 1 up to EOS (up to approximately 6 years); Cycle length=28 days",
                "name": "Cmax of Fulvestrant",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Predose (0-2 hours before inavolisib dosing) on Cycle 1 Day 1 up to EOS (up to approximately 6 years); Cycle length=28 days",
                "name": "Cmax of Letrozole",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Predose (0-2 hours before inavolisib) dosing) on Cycle 1 Day 1 up to Cycle 6; Cycle length=28 days",
                "name": "Cmax of Palbociclib",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Predose (0-2 hours before inavolisib dosing) on Cycle 1 Day 1 up to EOS (up to approximately 6 years); Cycle length=21 days",
                "name": "Cmax of Pertuzumab",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Predose (0-2 hours before inavolisib dosing) on Cycle 1 Day 1 up to EOS (up to approximately 6 years); Cycle length=21 days",
                "name": "Cmax of Trastuzumab",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "From first occurrence of a documented objective response (CR or PR) to disease progression or death from any cause, whichever occurs first (up to approximately 6 years)",
                "name": "Duration of Response, as Assessed by RECIST v1.1",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Predose (0-2 hours before dosing) on Cycle 1 Day 1 up to EOS (up to approximately 6 years); Cycle length=28 days (Cycle 1 of Stage 1 Arm A=35 days)",
                "name": "Half-Life of Inavolisib",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Predose (0-2 hours before dosing) on Cycle 1 Day 1 up to EOS (up to approximately 6 years); Cycle length=28 days (Cycle 1 of Stage 1 Arm A=35 days)",
                "name": "Maximum Plasma Concentration (Cmax) of Inavolisib",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Predose (0-2 hours before dosing) on Cycle 1 Day 1 up to EOS (up to approximately 6 years); Cycle length=28 days (Cycle 1 of Stage 1 Arm A=35 days)",
                "name": "Minimum Plasma Concentration (Cmin) of Inavolisib",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Day 1 up to 6 years",
                "name": "Percentage of Participants With Adverse Events and Serious Adverse Events",
                "description": null,
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Baseline up to disease progression or death from any cause, whichever occurs first (up to approximately 6 years)",
                "name": "Percentage of Participants With Clinical Benefit as Assessed by RECIST v1.1",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Baseline up to occurrence of complete response (CR) or partial response (PR) on 2 consecutive occasions >/=4 weeks apart (up to approximately 6 years)",
                "name": "Percentage of Participants With Objective Response as Assessed by Response Evaluation Criteria in Solid Tumors (RECIST), Version 1.1 (v1.1)",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Baseline up to disease progression or death from any cause, whichever occurs first (up to approximately 6 years)",
                "name": "Progression Free Survival (PFS) as Assessed by RECIST v1.1",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Day 1 up to Day 28 (for Stage 1 Arm A: Day 1 up to Day 35)",
                "name": "Recommended Phase II Dose of Inavolisib",
                "description": null,
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Day 1 up to Day 28 (for Stage 1 Arm A: Day 1 up to Day 35)",
                "name": "Stage 1: Percentage of Participants With Dose Limiting Toxicities",
                "description": null,
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Predose (0-2 hours before dosing) on Cycle 1 Day 1 up to EOS (up to approximately 6 years); Cycle length=28 days (Cycle 1 of Stage 1 Arm A=35 days)",
                "name": "Time to Cmax (tmax) of Inavolisib",
                "description": null,
                "type_code": "SECONDARY"
            }
        ],
        "phase": "I",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 9,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT03006172",
        "biomarkers": [
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "GENETIC_SEQ",
                    "Gene Mutant",
                    "Gene Mutation",
                    "Gene Variation",
                    "alternative"
                ],
                "nci_thesaurus_concept_id": "C97927",
                "name": "Gene Variant",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C3910",
                    "C97926",
                    "C36391"
                ],
                "parents": [
                    "C36391"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "ERBB2 Negative",
                    "HER-2 Negative",
                    "HER2 Negative"
                ],
                "nci_thesaurus_concept_id": "C68749",
                "name": "HER2/Neu Negative",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C165233",
                    "C94299",
                    "C20719",
                    "C35681",
                    "C21295",
                    "C77140",
                    "C21281",
                    "C20103",
                    "C16612",
                    "C25871",
                    "C16152",
                    "C3367",
                    "C25872",
                    "C17756",
                    "C25870",
                    "C36292"
                ],
                "parents": [
                    "C16152",
                    "C165233",
                    "C17756"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20719",
                "name": "Receptor Tyrosine Kinase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C21281",
                    "C16612",
                    "C20103",
                    "C25872",
                    "C25871",
                    "C25870",
                    "C21295"
                ],
                "parents": [
                    "C20103",
                    "C25872"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Genes"
                ],
                "nci_thesaurus_concept_id": "C16612",
                "name": "Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "branch"
                ],
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "PGR",
                    "PR",
                    "Progesterone Receptor Gene"
                ],
                "nci_thesaurus_concept_id": "C28656",
                "name": "PGR Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "ancestors": [
                    "C21295",
                    "C16612",
                    "C20103",
                    "C20420",
                    "C20709",
                    "C54362"
                ],
                "parents": [
                    "C20709"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Chromosomal, Gene, or Protein Abnormality",
                    "Cytogenetic or Molecular Genetic Abnormality",
                    "Genetic Abnormality",
                    "MOLECULAR_ABNORMALITY",
                    "Molecular Alteration"
                ],
                "nci_thesaurus_concept_id": "C3910",
                "name": "Molecular Abnormality",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [
                    "branch"
                ],
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36327",
                "name": "Gene Abnormality",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C97926",
                    "C36391",
                    "C3910"
                ],
                "parents": [
                    "C36391"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Absent",
                    "LOST",
                    "Loss of Expression",
                    "Negative",
                    "Not Expressed"
                ],
                "nci_thesaurus_concept_id": "C165233",
                "name": "Expression Negative",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C3367",
                    "C35681"
                ],
                "parents": [
                    "C35681"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25871",
                "name": "Phosphotransferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C21281",
                    "C25870",
                    "C16612"
                ],
                "parents": [
                    "C25870"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Diagnostic Test Result",
                    "Test Result"
                ],
                "nci_thesaurus_concept_id": "C77140",
                "name": "Clinical Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "ancestors": [
                    "C3367"
                ],
                "parents": [
                    "C3367"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Negative"
                ],
                "nci_thesaurus_concept_id": "C35681",
                "name": "Negative Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C3367"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "1-Phosphatidylinositol 3-Kinase Gene Mutation",
                    "PI3 Kinase Gene Mutation",
                    "PI3-Kinase Gene Mutation",
                    "PI3K Family Gene Mutation",
                    "PI3K Mutation",
                    "PIK3 Gene Mutation",
                    "Phosphatidylinositide 3-Kinase Gene Mutation",
                    "Phosphatidylinositol 3 Kinase Gene Mutation",
                    "Phosphatidylinositol 3-Kinase Gene Mutation",
                    "Phosphatidylinositol-3-Kinase Gene Mutation",
                    "Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Gene Mutation"
                ],
                "nci_thesaurus_concept_id": "C157554",
                "name": "PI3K Gene Mutation",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C97926",
                    "C36327",
                    "C137953",
                    "C36391",
                    "C3910"
                ],
                "parents": [
                    "C137953"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Expressed",
                    "Expression Detected"
                ],
                "nci_thesaurus_concept_id": "C177692",
                "name": "Expression Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C3367",
                    "C35682",
                    "C36292"
                ],
                "parents": [
                    "C35682"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21295",
                "name": "Ligand Binding Protein Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Positive",
                    "positive test result"
                ],
                "nci_thesaurus_concept_id": "C35682",
                "name": "Positive Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C3367",
                    "C36292"
                ],
                "parents": [
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20103",
                "name": "Receptor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612",
                    "C21295"
                ],
                "parents": [
                    "C21295"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "PGR Positive",
                    "PR Positive",
                    "PR+",
                    "Positive"
                ],
                "nci_thesaurus_concept_id": "C15496",
                "name": "Progesterone Receptor Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C177692",
                    "C94299",
                    "C21295",
                    "C28656",
                    "C77140",
                    "C20103",
                    "C16612",
                    "C101267",
                    "C20420",
                    "C38349",
                    "C3367",
                    "C35682",
                    "C20709",
                    "C54362",
                    "C188928",
                    "C36292",
                    "C16149"
                ],
                "parents": [
                    "C101267",
                    "C16149",
                    "C28656"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Phosphatidylinositol Kinase Family Gene",
                    "Phosphatidylinositol Kinase Gene",
                    "Phosphoinositol Kinase Gene"
                ],
                "nci_thesaurus_concept_id": "C26072",
                "name": "Phosphoinositol Kinase Family Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C21281",
                    "C16612",
                    "C25872",
                    "C25871",
                    "C25870"
                ],
                "parents": [
                    "C25872"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "LAB_RESULT",
                    "Lab Findings",
                    "Lab Value",
                    "Laboratory Finding",
                    "Laboratory Report",
                    "Labs",
                    "Test Result",
                    "test_result"
                ],
                "nci_thesaurus_concept_id": "C36292",
                "name": "Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ER Alpha Status",
                    "ER Status",
                    "ER-Alpha Status",
                    "ERA Status",
                    "ESR Status",
                    "ESR1 Status",
                    "ESRA Status",
                    "ESTRR Status",
                    "Estrogen Receptor",
                    "Estrogen Receptor 1 Status",
                    "Estrogen Receptor Alpha Status",
                    "NR3A1 Status",
                    "Nuclear Receptor Subfamily 3 Group A Member 1 Status"
                ],
                "nci_thesaurus_concept_id": "C16150",
                "name": "Estrogen Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C3367",
                    "C77140",
                    "C20103",
                    "C16612",
                    "C20420",
                    "C38349",
                    "C94299",
                    "C54362",
                    "C188928",
                    "C20709",
                    "C21295",
                    "C36292"
                ],
                "parents": [
                    "C188928",
                    "C38349"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25870",
                "name": "Transferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C21281",
                    "C16612"
                ],
                "parents": [
                    "C21281"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Anomaly",
                    "DNA Sequence Variation",
                    "Genetic Abnormality",
                    "Genetic Alteration",
                    "Genetic Anomaly",
                    "Molecular Abnormality",
                    "Molecular Anomaly",
                    "Molecular Genetic Abnormality",
                    "Molecular Genetic Anomaly"
                ],
                "nci_thesaurus_concept_id": "C36391",
                "name": "Molecular Genetic Variation",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C97926",
                    "C3910"
                ],
                "parents": [
                    "C97926"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "PI3K Gene Mutation",
                    "PI3K-Alpha Gene Mutation",
                    "PI3KCA Gene Mutation",
                    "PIK3CA",
                    "PIK3CA Mutation",
                    "Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Gene Mutation",
                    "p110-alpha Gene Mutation"
                ],
                "nci_thesaurus_concept_id": "C96271",
                "name": "PIK3CA Gene Mutation",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C36391",
                    "C21281",
                    "C16612",
                    "C97927",
                    "C157554",
                    "C25872",
                    "C137953",
                    "C26072",
                    "C25871",
                    "C25870",
                    "C3910",
                    "C36327",
                    "C97926",
                    "C21220"
                ],
                "parents": [
                    "C157554",
                    "C21220",
                    "C97927"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ERBB2",
                    "Erb-b2 Receptor Tyrosine Kinase 2 Gene",
                    "HER2",
                    "HER2/Neu",
                    "NEU"
                ],
                "nci_thesaurus_concept_id": "C17756",
                "name": "ERBB2 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "ancestors": [
                    "C20719",
                    "C21295",
                    "C21281",
                    "C20103",
                    "C16612",
                    "C25871",
                    "C25872",
                    "C25870"
                ],
                "parents": [
                    "C20719"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "PIK3CA",
                    "Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Gene"
                ],
                "nci_thesaurus_concept_id": "C21220",
                "name": "PIK3CA Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "ancestors": [
                    "C21281",
                    "C16612",
                    "C25872",
                    "C26072",
                    "C25871",
                    "C25870"
                ],
                "parents": [
                    "C26072"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25872",
                "name": "Kinase Family Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C25871",
                    "C21281",
                    "C25870",
                    "C16612"
                ],
                "parents": [
                    "C25871"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ERBB2 Status",
                    "Her2/Neu Value"
                ],
                "nci_thesaurus_concept_id": "C16152",
                "name": "HER2/Neu Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C94299",
                    "C20719",
                    "C21295",
                    "C77140",
                    "C21281",
                    "C20103",
                    "C16612",
                    "C25871",
                    "C3367",
                    "C25872",
                    "C17756",
                    "C25870",
                    "C36292"
                ],
                "parents": [
                    "C17756",
                    "C94299"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "HR Status"
                ],
                "nci_thesaurus_concept_id": "C188928",
                "name": "Hormone Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C3367",
                    "C77140",
                    "C36292",
                    "C94299"
                ],
                "parents": [
                    "C94299"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "PI3K/ALK/MTOR Pathway Mutation",
                    "Phosphatidylinositol 3 Kinase/Anaplastic Lymphoma Kinase Receptor/Mammalian Target of Rapamycin Pathway Mutation",
                    "Phosphatidylinositol 3 Kinase/Mammalian Target of Rapamycin Pathway Mutation"
                ],
                "nci_thesaurus_concept_id": "C137953",
                "name": "PI3K/MTOR Pathway Mutation",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C97926",
                    "C36391",
                    "C36327",
                    "C3910"
                ],
                "parents": [
                    "C36327"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "VARIANT_TYPE",
                    "molecular consequence",
                    "molecular_consequence"
                ],
                "nci_thesaurus_concept_id": "C97926",
                "name": "Molecular Sequence Variation",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C3910"
                ],
                "parents": [
                    "C3910"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20709",
                "name": "Nuclear Receptor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C21295",
                    "C20103",
                    "C16612",
                    "C20420",
                    "C54362"
                ],
                "parents": [
                    "C20103",
                    "C20420"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Proto-Oncogene, Transcription Factor"
                ],
                "nci_thesaurus_concept_id": "C20420",
                "name": "Transcription Factor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C54362",
                    "C16612"
                ],
                "parents": [
                    "C54362"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Observable Entity"
                ],
                "nci_thesaurus_concept_id": "C3367",
                "name": "Finding",
                "semantic_types": [
                    "Finding"
                ],
                "type": [
                    "branch"
                ],
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "PgR Status",
                    "Progesterone Receptor"
                ],
                "nci_thesaurus_concept_id": "C16149",
                "name": "Progesterone Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C94299",
                    "C21295",
                    "C28656",
                    "C77140",
                    "C20103",
                    "C16612",
                    "C20420",
                    "C3367",
                    "C20709",
                    "C54362",
                    "C188928",
                    "C36292"
                ],
                "parents": [
                    "C188928",
                    "C28656"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C54362",
                "name": "Transcription Regulation Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C94299",
                "name": "Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C36292",
                    "C3367"
                ],
                "parents": [
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ER",
                    "ESR1",
                    "Estrogen Receptor 1 Gene"
                ],
                "nci_thesaurus_concept_id": "C38349",
                "name": "ESR1 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "ancestors": [
                    "C21295",
                    "C16612",
                    "C20103",
                    "C20420",
                    "C20709",
                    "C54362"
                ],
                "parents": [
                    "C20709"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "ER Alpha Positive",
                    "ER Positive",
                    "ER+",
                    "ER-Alpha Positive",
                    "ERA Positive",
                    "ESR Positive",
                    "ESR1 Positive",
                    "ESRA Positive",
                    "ESTRR Positive",
                    "Estrogen Receptor 1 Positive",
                    "Estrogen Receptor Alpha Positive",
                    "NR3A1 Positive",
                    "Nuclear Receptor Subfamily 3 Group A Member 1 Positive",
                    "Positive",
                    "Positive Estrogen Receptor"
                ],
                "nci_thesaurus_concept_id": "C15492",
                "name": "Estrogen Receptor Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C16150",
                    "C3367",
                    "C77140",
                    "C20103",
                    "C101267",
                    "C20420",
                    "C28656",
                    "C16612",
                    "C94299",
                    "C38349",
                    "C188928",
                    "C54362",
                    "C20709",
                    "C177692",
                    "C21295",
                    "C35682",
                    "C36292"
                ],
                "parents": [
                    "C101267",
                    "C16150",
                    "C38349"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C101267",
                "name": "Hormone Receptor Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C3367",
                    "C77140",
                    "C20103",
                    "C20420",
                    "C28656",
                    "C16612",
                    "C94299",
                    "C38349",
                    "C54362",
                    "C188928",
                    "C20709",
                    "C177692",
                    "C21295",
                    "C35682",
                    "C36292"
                ],
                "parents": [
                    "C177692",
                    "C188928",
                    "C28656",
                    "C38349"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21281",
                "name": "Enzyme Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            }
        ],
        "classification_code": null,
        "current_trial_status_date": "2016-11-30",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrent Solid Tumor",
                    "Relapsed Malignant Solid Neoplasm",
                    "Recurrent Malignant Solid Neoplasm",
                    "Relapsed Solid Neoplasm",
                    "Relapsed Solid Tumor",
                    "Recurrent Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C127153",
                "name": "Recurrent Malignant Solid Tumor",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C132146",
                    "C4813"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Solid Neoplasm",
                    "Metastatic Malignant Solid Neoplasm",
                    "Metastatic Solid Tumor"
                ],
                "nci_thesaurus_concept_id": "C127155",
                "name": "Metastatic Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C132146"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Locally Advanced Solid Tumor",
                    "Locally Advanced Malignant Solid Neoplasm",
                    "Locally Advanced Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C133093",
                "name": "Locally Advanced Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8524",
                    "C127155"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IIA Breast Cancer AJCC v7",
                    "Stage IIA Breast Cancer AJCC v6",
                    "Stage IIA Breast Cancer AJCC v6 and v7",
                    "Breast Cancer Stage IIA",
                    "Stage IIA Breast Carcinoma",
                    "Breast Carcinoma Stage IIA"
                ],
                "nci_thesaurus_concept_id": "C5454",
                "name": "Stage IIA Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7768"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Breast Cancer Stage IIB",
                    "Stage IIB Breast Cancer AJCC v6 and v7",
                    "Stage IIB Breast Carcinoma",
                    "Breast Carcinoma Stage IIB",
                    "Stage IIB Breast Cancer AJCC v6",
                    "Stage IIB Breast Cancer AJCC v7"
                ],
                "nci_thesaurus_concept_id": "C5455",
                "name": "Stage IIB Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7768"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage II Breast Cancer AJCC v6 and v7",
                    "Stage II Breast Cancer AJCC v7",
                    "Carcinoma of the Breast Stage II",
                    "Carcinoma of Breast Stage II",
                    "Stage II Breast Cancer AJCC v6",
                    "Breast Cancer Stage II",
                    "Stage II Breast Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C7768",
                "name": "Stage II Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C90513",
                    "C91230"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Breast Cancer, Recurrent",
                    "Recurrent Breast Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C7771",
                "name": "Recurrent Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C170726",
                    "C4872",
                    "C7619"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IA Breast Cancer AJCC v7"
                ],
                "nci_thesaurus_concept_id": "C85835",
                "name": "Stage IA Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C88375"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IB Breast Cancer AJCC v7"
                ],
                "nci_thesaurus_concept_id": "C85836",
                "name": "Stage IB Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C88375"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage I Breast Cancer AJCC v7"
                ],
                "nci_thesaurus_concept_id": "C88375",
                "name": "Stage I Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C91230"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Tumor",
                    "Tumor, secondary",
                    "Neoplasm, secondary"
                ],
                "nci_thesaurus_concept_id": "C36255",
                "name": "Secondary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor, metastatic",
                    "Metastatic Tumor",
                    "Neoplasm, metastatic",
                    "Metastatic"
                ],
                "nci_thesaurus_concept_id": "C3261",
                "name": "Metastatic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Tumor, malignant, NOS",
                    "Malignancy",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease",
                    "Malignant Growth",
                    "CA",
                    "Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Solid Neoplasm",
                    "Solid Tumour",
                    "Solid tumor, NOS"
                ],
                "nci_thesaurus_concept_id": "C9292",
                "name": "Solid Tumor",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Cancer"
                ],
                "nci_thesaurus_concept_id": "C36263",
                "name": "Metastatic Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C3261"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C132146",
                "name": "Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9292",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Diseases",
                    "Disease",
                    "Diseases and Disorders",
                    "disease_term",
                    "Diagnosis",
                    "Disease or Disorder, Non-Neoplastic",
                    "disease type",
                    "Disorders",
                    "Disease or Disorder",
                    "Disorder",
                    "condition",
                    "disease_type"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Cancer",
                    "Secondary Malignancy"
                ],
                "nci_thesaurus_concept_id": "C4968",
                "name": "Secondary Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36255",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm",
                    "Neoplasms, NOS",
                    "tumor",
                    "Neoplastic Growth",
                    "Tumor, NOS",
                    "Neoplasia",
                    "Neoplasm, NOS",
                    "Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Neoplasm Recurrence",
                    "Recurrence",
                    "Recurrent Tumor",
                    "Recurrent"
                ],
                "nci_thesaurus_concept_id": "C4798",
                "name": "Recurrent Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C3263",
                "name": "Neoplasm by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Breast Carcinoma by AJCC v7 Stage"
                ],
                "nci_thesaurus_concept_id": "C91230",
                "name": "Breast Cancer by AJCC v7 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4872"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C170726",
                "name": "Recurrent Malignant Breast Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C9335",
                    "C4813"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Epithelioma",
                    "Epithelioma, malignant",
                    "Epithelial Neoplasms, NOS"
                ],
                "nci_thesaurus_concept_id": "C3709",
                "name": "Epithelial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4741"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Relapsed Cancer",
                    "Relapsed Carcinoma",
                    "Recurrent Cancer"
                ],
                "nci_thesaurus_concept_id": "C7619",
                "name": "Recurrent Carcinoma",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4813",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Carcinoma of the Breast",
                    "Cancer of Breast",
                    "Carcinoma of Breast",
                    "Breast cancer, NOS",
                    "Mammary Carcinoma",
                    "Breast Carcinoma",
                    "Cancer of the Breast"
                ],
                "nci_thesaurus_concept_id": "C4872",
                "name": "Breast Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C9335",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Breast Carcinoma by AJCC v6 Stage"
                ],
                "nci_thesaurus_concept_id": "C90513",
                "name": "Breast Cancer by AJCC v6 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4872"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Breast Disease",
                    "Breast Diseases"
                ],
                "nci_thesaurus_concept_id": "C26709",
                "name": "Breast Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Tumor of Breast",
                    "Malignant Breast Tumor",
                    "Malignant Tumor of the Breast",
                    "Malignant Neoplasm of Breast",
                    "Malignant Neoplasm of the Breast"
                ],
                "nci_thesaurus_concept_id": "C9335",
                "name": "Malignant Breast Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C2910"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Epithelial Neoplasm",
                    "Epithelial tumor, malignant",
                    "Carcinoma",
                    "Carcinoma, NOS",
                    "Malignant Epithelioma",
                    "Epithelioma Malignant",
                    "CARCINOMA, MALIGNANT",
                    "Malignant Epithelial Tumor",
                    "Epithelial Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C2916",
                "name": "Other Carcinoma",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C9305",
                    "C3709"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Disease by Site"
                ],
                "nci_thesaurus_concept_id": "C27551",
                "name": "Disorder by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrence",
                    "Recurrent Cancer",
                    "Recurrent Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C4813",
                "name": "Recurrent Malignant Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4798",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Tumor_Morphology",
                    "Tumor Morphology"
                ],
                "nci_thesaurus_concept_id": "C4741",
                "name": "Neoplasm by Morphology",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Tumor of the Breast",
                    "Tumor of Breast",
                    "Breast Tumor",
                    "Neoplasm of the Breast",
                    "Neoplasm of Breast"
                ],
                "nci_thesaurus_concept_id": "C2910",
                "name": "Breast Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C26709",
                    "C3263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Locally Advanced Cancer",
                    "regional cancer",
                    "Locally advanced",
                    "Locally Metastatic Malignant Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C8524",
                "name": "Locally Advanced Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "GO39374",
        "active_sites_count": 4,
        "lead_org_cancer_center": null,
        "arms": [
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Enzyme Inhibitor Drug",
                            "Enzyme Antagonist",
                            "Enzyme Inhibitor Agent"
                        ],
                        "nci_thesaurus_concept_id": "C471",
                        "name": "Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Ibrance"
                        ],
                        "nci_thesaurus_concept_id": "C49176",
                        "name": "Palbociclib",
                        "description": "An orally available cyclin-dependent kinase (CDK) inhibitor with potential antineoplastic activity. Palbociclib selectively inhibits cyclin-dependent kinase 4 (CDK4) and 6 (CDK6), thereby inhibiting retinoblastoma (Rb) protein phosphorylation early in the G1 phase leading to cell cycle arrest. This suppresses DNA replication and decreases tumor cell proliferation. CDK4 and 6 are serine/threonine kinases that are upregulated in many tumor cell types and play a key role in the regulation of cell cycle progression. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C192742",
                            "C192741",
                            "C129825"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C132166",
                        "name": "Inavolisib",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C2152",
                            "C129825"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Ab",
                            "Anti-cancer Antibody",
                            "Anticancer Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C129822",
                        "name": "Antineoplastic Antibody",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C129821"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Biological Agent",
                            "Antineoplastic Biological",
                            "Antineoplastic Biotherapeutic",
                            "Anticancer Biological"
                        ],
                        "nci_thesaurus_concept_id": "C129821",
                        "name": "Antineoplastic Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Protein Antagonist",
                            "Anti-cancer Protein Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C129824",
                        "name": "Antineoplastic Protein Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2189"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Perjeta"
                        ],
                        "nci_thesaurus_concept_id": "C38692",
                        "name": "Pertuzumab",
                        "description": "A humanized recombinant monoclonal antibody directed against the extracellular dimerization domain of the HER-2 tyrosine kinase receptor. Binding of the antibody to the dimerization domain of the HER-2 tyrosine kinase receptor protein directly inhibits the ability of the HER-2 tyrosine kinase receptor protein (the most common pairing partner) to dimerize with other HER tyrosine kinase receptor proteins; inhibiting receptor protein dimerization prevents the activation of HER signaling pathways, resulting in tumor cell apoptosis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C155711"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Estrogen Inhibitor",
                            "Estrogen Antagonist",
                            "Antiestrogenic",
                            "Antiestrogen Therapy Agent",
                            "Antiestrogens",
                            "Antiestrogen",
                            "Anti-Estrogens"
                        ],
                        "nci_thesaurus_concept_id": "C481",
                        "name": "Antiestrogen Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C129818",
                            "C547"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Faslodex"
                        ],
                        "nci_thesaurus_concept_id": "C1379",
                        "name": "Fulvestrant",
                        "description": "A synthetic estrogen receptor antagonist.  Unlike tamoxifen (which has partial agonist effects) and the aromatase inhibitors (which reduce the estrogen available to tumor cells), fulvestrant binds competitively to estrogen receptors in breast cancer cells, resulting in estrogen receptor deformation and decreased estrogen binding. In vitro studies indicate that fulvestrant reversibly inhibits the growth of tamoxifen-resistant, estrogen-sensitive, human breast cancer cell lines. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C2116"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastics",
                            "Anti-Cancer Agents",
                            "Antineoplastic Drugs",
                            "Antiproliferative Agents",
                            "Tumor-Specific Treatment Agents",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Anti-Tumor Agents",
                            "Antiproliferative Drugs",
                            "Cancer Drug",
                            "Anti-Tumor Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "PI3-Kinase Inhibitors",
                            "Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Inhibitor",
                            "Phosphatidylinositide 3-Kinase Inhibitor",
                            "Phosphatidylinositol 3-kinase Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C2152",
                        "name": "PI3K Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1742",
                            "C163758",
                            "C1404"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "ERBB2-Targeting Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163760",
                        "name": "HER2-targeting Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C163758"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1404",
                        "name": "Protein Kinase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C471"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C78276",
                        "name": "Agent Affecting Digestive System or Metabolism",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Drug Substance",
                            "Pharmaceutical Agent",
                            "Pharmaceuticals",
                            "Drug",
                            "Pharmacologic Agent",
                            "Pharmacological Substance",
                            "Agent"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C2189",
                        "name": "Signal Transduction Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Femara"
                        ],
                        "nci_thesaurus_concept_id": "C1527",
                        "name": "Letrozole",
                        "description": "A nonsteroidal inhibitor of estrogen synthesis with antineoplastic activity.  As a third-generation aromatase inhibitor, letrozole selectively and reversibly inhibits aromatase, which may result in growth inhibition of estrogen-dependent breast cancer cells. Aromatase, a cytochrome P-450 enzyme  localized to the endoplasmic reticulum of the cell and found in many tissues including those of the premenopausal ovary, liver, and breast, catalyzes the aromatization of androstenedione and testosterone into estrone and estradiol, the final step in estrogen biosynthesis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C2018"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-ErbB2 Monoclonal Antibody",
                            "Anti-HER-2 Monoclonal Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C155711",
                        "name": "Anti-HER2 Monoclonal Antibody",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C129822",
                            "C163760",
                            "C20401"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C98234",
                        "name": "Biguanide Antidiabetic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C29711"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Hormonal Therapy Agent",
                            "Hormone Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C147908",
                        "name": "Hormone Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Kanjinti",
                            "Ogivri",
                            "Ontruzant",
                            "Trazimera",
                            "Herzuma",
                            "Herceptin"
                        ],
                        "nci_thesaurus_concept_id": "C1647",
                        "name": "Trastuzumab",
                        "description": "A recombinant humanized monoclonal antibody directed against the human epidermal growth factor receptor 2 (HER2). After binding to HER2 on the tumor cell surface, trastuzumab induces an antibody-dependent cell-mediated cytotoxicity against tumor cells that overexpress HER2. HER2 is overexpressed by many adenocarcinomas, particularly breast adenocarcinomas. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C155711"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Monoclonal Antibodies",
                            "Monoclonal Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C20401",
                        "name": "Monoclonal Antibody Therapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C308",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Molecularly Targeted Therapy Agent",
                            "Anti-tumor Targeted Therapy Agent",
                            "Targeted Agent",
                            "Targeted Therapeutic Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163758",
                        "name": "Targeted Therapy Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immune Mediators",
                            "Immune Modulators",
                            "Immunopotentiators",
                            "Immunomodulatory Agent",
                            "Immunotherapy Agent",
                            "Immunotherapeutic Agent",
                            "Immune Regulators",
                            "BRM",
                            "Biomodulators",
                            "Immunomodulators",
                            "Immunomodulating Agent",
                            "Biological Response Modifier"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Molecularly Targeted Therapy Agent",
                            "Anti-tumor Targeted Therapy Agent",
                            "Targeted Agent",
                            "Targeted Therapeutic Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163758",
                        "name": "Targeted Therapy Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Hormonal Agent",
                            "Antineoplastic Hormonal Therapeutic",
                            "Antineoplastic Endocrinal Agent"
                        ],
                        "nci_thesaurus_concept_id": "C129818",
                        "name": "Antineoplastic Hormonal/Endocrine Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C147908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Selective Estrogen Receptor Degrader",
                            "SERD",
                            "SERDs"
                        ],
                        "nci_thesaurus_concept_id": "C2116",
                        "name": "Selective Estrogen Receptor Down Regulator",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C163758",
                            "C481"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "CDK Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C2185",
                        "name": "Cyclin-Dependent Kinase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C163758",
                            "C1404"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Drug Substance",
                            "Pharmaceutical Agent",
                            "Pharmaceuticals",
                            "Drug",
                            "Pharmacologic Agent",
                            "Pharmacological Substance",
                            "Agent"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antihormone Agents",
                            "Hormone Antagonist"
                        ],
                        "nci_thesaurus_concept_id": "C547",
                        "name": "Antihormone Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C147908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastics",
                            "Anti-Cancer Agents",
                            "Antineoplastic Drugs",
                            "Antiproliferative Agents",
                            "Tumor-Specific Treatment Agents",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Anti-Tumor Agents",
                            "Antiproliferative Drugs",
                            "Cancer Drug",
                            "Anti-Tumor Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "CDK4 Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C192741",
                        "name": "Cyclin-Dependent Kinase 4 Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2185"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1892",
                        "name": "Chemopreventive Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Aromatase Inhibitor",
                            "Estrogen Synthase Inhibitor",
                            "Estrogen Synthetase Inhibitor",
                            "Androstenedione Aromatase Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C1740",
                        "name": "Aromatase Inhibition Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C163758",
                            "C481",
                            "C129825"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Angiogenesis Blockers",
                            "Angiogenesis Antagonists",
                            "Antiangiogenesis Agents",
                            "Antiangiogenic Agent",
                            "Anti-Angiogenic Agents"
                        ],
                        "nci_thesaurus_concept_id": "C1742",
                        "name": "Angiogenesis Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-diabetics",
                            "Antidiabetic Agent"
                        ],
                        "nci_thesaurus_concept_id": "C29711",
                        "name": "Anti-diabetic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C78276"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Enzyme Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C129825",
                        "name": "Antineoplastic Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C129824",
                            "C471"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C61612",
                        "name": "Metformin",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C98234",
                            "C1892"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Non-Steroidal Androstenedione Aromatase Inhibitor",
                            "Non-Steroidal Estrogen Synthetase Inhibitor",
                            "Non-Steroidal Estrogen Synthase Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C2018",
                        "name": "Non-Steroidal Aromatase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1740"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Biopharmaceuticals",
                            "Immunologic, Immunochemical",
                            "Immunologics",
                            "Biological Products",
                            "Biologicals",
                            "Biologics"
                        ],
                        "nci_thesaurus_concept_id": "C307",
                        "name": "Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "CDK6 Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C192742",
                        "name": "Cyclin-Dependent Kinase 6 Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2185"
                        ]
                    }
                ],
                "name": "Arm not specified",
                "description": null,
                "type": null
            },
            {
                "interventions": [],
                "name": "Stage I Arm A: Inavolisib Single Agent",
                "description": "Participants will receive inavolisib in escalating dose levels with starting dose of 6 milligrams (mg). Participants will receive single dose of inavolisib on Day 1 of Cycle 1 followed by once daily from Day 8 of Cycle 1. (Cycle length: 35 days for Cycle 1 and 28 days for all other cycles). Participants will continue treatment until the end of the study in the absence of unacceptable toxicities and unequivocal disease progression.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Stage I Arm B: Inavolisib + Palbociclib + Letrozole",
                "description": "Participants will receive inavolisib in escalating dose levels (starting dose 3 mg) on Days 1-28, palbociclib on Days 1-21, and letrozole on Days 1-28 of each 28-day cycle. Participants will continue treatment until the end of the study in the absence of unacceptable toxicities and unequivocal disease progression.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Stage I Arm C: Inavolisib + Letrozole",
                "description": "Participants will receive inavolisib in escalating dose levels along with letrozole on Days 1-28 of each 28-day cycle. The starting dose of inavolisib will not exceed the starting dose in Stage I Arm A. Participants will continue treatment until the end of the study in the absence of unacceptable toxicities and unequivocal disease progression.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Stage II Arm B: Inavolisib + Palbociclib + Letrozole",
                "description": "Participants will receive inavolisib on Days 1-28 in combination with palbociclib on Days 1-21 and letrozole on Days 1-28 of each 28-day cycle. Dose of inavolisib will be decided based on the results of Stage I Arm B. Participants will continue treatment until the end of the study in the absence of unacceptable toxicities and unequivocal disease progression.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Stage II Arm C: Inavolisib + Letrozole",
                "description": "Participants will receive inavolisib in combination with letrozole on Days 1-28 of each 28-day cycle. Dose of inavolisib will be decided based on the results of Stage I Arm C. Participants will continue treatment until the end of the study in the absence of unacceptable toxicities and unequivocal disease progression.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Stage II Arm D: Inavolisib + Fulvestrant",
                "description": "Participants will receive inavolisib on Days 1-28 in combination with fulvestrant on Day 1 and 15 of Cycle 1 and then on Day 1 from Cycle 2 (cycle length: 28 days). Dose of inavolisib will be decided based on the results of Stage I Arm C. Participants will continue treatment until the end of the study in the absence of unacceptable toxicities and unequivocal disease progression.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Stage II Arm E: Inavolisib + Palbociclib + Fulvestrant",
                "description": "Participants will receive inavolisib (Days 1-28) in combination with palbociclib (Days 1-21) and fulvestrant (Days 1 and 15 of Cycle 1; Day 1 for subsequent cycles)(Cycle = 28 days). Dose of inavolisib will be determined from the results of Stage I Arm B. Participants will continue treatment until the end of the study in the absence of unacceptable toxicities and unequivocal disease progression.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Stage II Arm F: Inavolisib + Palbociclib + Fulvestrant + Metformin",
                "description": "Participants will receive inavolisib (Days 1-28) in combination with palbociclib (Days 1-21), fulvestrant (Days 1 and 15 of Cycle 1; Day 1 for subsequent cycles) and metformin (Days 1-28)(Cycle = 28 days). Dose of inavolisib will be determined from the results of Stage I Arm B. Participants will continue treatment until the end of the study in the absence of unacceptable toxicities and unequivocal disease progression.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Stage II Arm G: Inavolisib + Trastuzumab + Pertuzumab",
                "description": "Participants will receive inavolisib in combination with trastuzumab and pertuzumab (Days 1-21). Dose of inavolisib will be determined from the results of Stage I Arm A. Participants will continue treatment until the end of the study in the absence of unacceptable toxicities and unequivocal disease progression.",
                "type": "EXPERIMENTAL"
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2017-00262",
        "why_study_stopped": null,
        "brief_summary": "This is an open-label, multicenter, Phase I study designed to evaluate the safety,\r\n      tolerability, and pharmacokinetics of inavolisib administered orally as a single agent in\r\n      patients with locally advanced or metastatic PIK3CA-mutant solid tumors, including breast\r\n      cancer, and in combination with standard-of-care endocrine and/or targeted therapies for the\r\n      treatment of locally advanced or metastatic PIK3CA-mutant breast cancer. Participants will be\r\n      enrolled in two stages: a dose-escalation stage (Stage I) and an expansion stage (Stage II).\r\n      Participants will be assigned to one of seven regimens: inavolisib as a single agent (Arm A),\r\n      inavolisib in combination with palbociclib and letrozole (Arm B), inavolisib in combination\r\n      with letrozole (Arm C), inavolisib in combination with fulvestrant (Arm D), inavolisib in\r\n      combination with palbociclib and fulvestrant (Arm E), inavolisib in combination with\r\n      palbociclib, fulvestrant, and metformin (Arm F), and inavolisib in combination with\r\n      trastuzumab and pertuzumab (and letrozole or fulvestrant, if applicable (Arm G)).",
        "brief_title": "To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer",
        "status_history": [
            {
                "status_date": "2016-11-30T00:00:00",
                "status": "ACTIVE"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 256,
        "prior_therapy": [],
        "_current_trial_status_sort_order": 0,
        "start_date": "2016-12-13",
        "record_verification_date": "2023-03-01",
        "ctep_id": null,
        "current_trial_status": "Active",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": "OPEN",
            "role_investigator": null,
            "role_outcome_assessor": null,
            "role_subject": null,
            "allocation_code": "Non-Randomized Trial"
        },
        "acronym": null,
        "nci_programs": [],
        "nci_funded": "Indirect",
        "anatomic_sites": [
            "Multiple"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": null,
        "study_source": "Industrial",
        "completion_date": "2024-11-30",
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]